ALTRAVAX, INC.

Company Information

Company Name
ALTRAVAX, INC.
Address
3233 15TH ST S
FARGO, ND, -
Phone
1 --
URL
n/a
DUNS
832765932
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$3,595,625.00
6
Chart code to be here

Award List

  1. VLP-Based Antibody-Inducing Vaccines for HIV-1

    Amount: $599,688.00

    DESCRIPTION (provided by applicant): The HIV-1 epidemic has resulted in ~2.7 million new infections in 2007 for a total of ~33 million people living with HIV/AIDS. Clinical trials have shown that HIV- ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Improved Vaccines for Influenza B Virus

    Amount: $598,391.00

    DESCRIPTION (provided by applicant): Influenza is a major cause of morbidity and mortality around the world. In the United States, seasonal epidemics of flu occur from late fall to early spring affec ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. Designing Improved HIV-1 Envelope Proteins as Vaccine Candidates

    Amount: $599,074.00

    DESCRIPTION (provided by applicant): The HIV-1 epidemic has resulted in ~2.7 million new infections in 2007 for a total of ~33 million people living with HIV/AIDS. Clinical trials have shown that HIV- ...

    SBIR Phase I 2010 Department of Health and Human Services
  4. Novel Tetravalent Vaccines for Dengue Virus

    Amount: $598,472.00

    DESCRIPTION (provided by applicant): Dengue virus infection is an emerging disease and an expanding global health problem. More than one-third of the world's population is at risk for transmissio ...

    SBIR Phase I 2012 Department of Health and Human Services
  5. Germline-Specific Immunogens for the Induction of Neutralizing Antibodies to HIV-

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Vaccines are urgently needed to slow the spread of the HIV/AIDS epidemic, and immunogens that can induce neutralizing antibodies remain an important goal of vaccin ...

    SBIR Phase I 2012 Department of Health and Human Services
  6. Novel Therapeutic Vaccines for Chronic HBV

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Hepatitis B virus (HBV) is a noncytopathic, hepatotropic DNA virus that results in a self-limited acute infection in a majority of otherwise healthy individuals bu ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government